We invite you to read Tim Boreham’s latest interview with our CEO and co-founder Dr German Arango.
Tim Boreham is an experienced business writer who has written for three decades in major business publications, specializing in banking, accounting, resources, technology, telecommunications, agriculture, property trusts and – of course – the life sciences. He became known as the writer of the Criterion investment column that analyzed ASX listed companies in a style accessible to retail investors. A peculiarity of the column was that it offered “buy” and “sell” recommendations in a journalistic context.
The interview explored how our disruptive technology is democratizing access to affordable, state-of-the-art technology to improve productivity and deliver better patient outcomes. Also how, through a new business model, it leverages AQUILA’s multi-tenancy capabilities to provide small and medium-sized customers with an affordable and accessible RIS/PACS product.